Core AI Holdings Appoints Arie Goor as CFO with 15+ Years Leadership
CHAI•Core AI Holdings named Arie Goor as Chief Financial Officer effective July 1, 2026, bringing over 15 years of financial leadership experience across biotechnology, medical device, and technology sectors. His track record includes CFO roles at Regentis Biomaterials and Revium Rx, where he led IPOs and cross-border capital transactions.
1. Appointment Details
Core AI Holdings appointed Arie Goor as its Chief Financial Officer effective July 1, 2026. In this role, he will oversee the company’s finance operations, reporting, and capital markets strategy as the business scales its AI infrastructure offerings.
2. Professional Background
Goor brings over 15 years of executive financial leadership in biotechnology, medical devices, and technology sectors. His prior roles include CFO at Regentis Biomaterials (Oct 2022–Jan 2026) and Revium Rx (Jun 2023–May 2026), where he managed initial public offerings and cross-border financing transactions.
3. Strategic Implications
With deep expertise in capital markets and regulatory compliance, Goor’s appointment strengthens Core AI’s financial governance and positions the company to execute its long-term growth strategy. His leadership is expected to drive shareholder value through enhanced funding capabilities and strategic financial planning.
